Yalena Amador‐Cañizares

Immunogenicity of CIGB‐230, a therapeutic DNA vaccine preparation, in HCV‐chronically infected individuals in a Phase I clinical trial

Liz Alvarez‐Lajonchere, Naglaa H. Shoukry, Bienvenido Grá et al. · Journal of Viral Hepatitis · 2008 · 90 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Regulation of Hepatitis C Virus Genome Replication by Xrn1 and MicroRNA-122 Binding to Individual Sites in the 5′ Untranslated Region

Patricia A. Thibault, Adam Huys, Yalena Amador‐Cañizares et al. · Journal of Virology · 2015 · 80 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +17

miR-122 does not impact recognition of the HCV genome by innate sensors of RNA but rather protects the 5′ end from the cellular pyrophosphatases, DOM3Z and DUSP11

Yalena Amador‐Cañizares, Annie Bernier, Joyce A. Wilson et al. · Nucleic Acids Research · 2018 · 62 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

miR-122, small RNA annealing and sequence mutations alter the predicted structure of the Hepatitis C virus 5′ UTR RNA to stabilize and promote viral RNA accumulation

Yalena Amador‐Cañizares, Mamata Panigrahi, Adam Huys et al. · Nucleic Acids Research · 2018 · 40 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17

HCV-specific immune responses induced by CIGB-230 in combination with IFN-α plus ribavirin

Yalena Amador‐Cañizares · World Journal of Gastroenterology · 2014 · 14 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17